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Abstract GIRK (G protein-activated inward-rectifying K+
channel) channels, important regulators of membrane excitabil-
ity in the heart and in the central nervous, are activated by
interaction with LQ subunits from heterotrimeric G proteins
upon receptor stimulation. For activation interaction of
the channel with phosphatidylinositol 4,5-bisphosphate
(PtIns(4,5)P2) is conditional. Previous studies have provided
evidence that in myocytes PtIns(4,5)P2 levels relevant to
GIRK channel regulation are under regulatory control of recep-
tors activating phospholipase C. In the present study a phospha-
tidyl-4-phosphate 5-kinase was expressed in atrial myocytes by
transient transfection. This did not a¡ect basal properties of
GIRK current activated by acetylcholine via M2 receptors but
completely abolished inhibition of guanosine triphosphate-Q-S
activated current by endothelin-1 or K-adrenergic agonists. We
conclude that though PtIns(4,5)P2 is conditional for channel
gating, its normal level in the membrane is not limiting basal
function of GIRK channels. Moreover, our data provide further
evidence for a regulation of GIRK channels by K1A receptors
and endothelin-A receptors, endogenously expressed in atrial
myocytes, via depletion of PtIns(4,5)P2.
. 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
G protein-activated inwardly rectifying Kþ (GIRK) chan-
nels expressed in cardiac supraventricular tissue and various
types of neurons and endocrine cells couple to many di¡erent
seven-helix receptors and are important regulators of mem-
brane excitability. Activation of appropriate receptors causes
release of LQ subunits from heterotrimeric G proteins. Direct
interaction of GLQ with the subunits of GIRK channels in-
creases their open probability [1,2]. The four cloned mamma-
lian GIRK subunits (GIRK1^4 or Kir3.1^3.4) belong to the
family of inwardly rectifying Kþ channels (Kir). Members of
this family are either constitutively active or are regulated by a
variety of intracellular factors. For some members it has been
demonstrated that their gating requires phosphatidylinositol
phosphates. Apart from GLQ -mediated activation, which is
conditional for transmitter-mediated GIRK current, these
channels have been shown to be modulated by phosphatidyl-
inositol 4,5-bisphosphate (PtIns(4,5)P2) and intracellular Naþ
ions [3^5]. Based on these detailed studies analyzing the e¡ects
of PtIns(4,5)P2 it is assumed that its binding to the channel is
conditional for gating, and that GLQ stabilizes the channel-
PtIns(4,5)P2 interactions.
Recent studies have demonstrated that stimulation of recep-
tors in atrial myocytes, which activate phospholipase C (PLC)
via Gq=11; such as the adrenergic K1 receptor (K1-AR) or the
endothelin-A receptor (ETA-R) causes inhibition of atrial
GIRK current. This inhibition showed clear symptoms of
being mediated by depletion of PtIns(4,5)P2 [6^8], supporting
the notion that PtIns(4,5)P2 levels required for channel gating
are under regulatory control.
The level of PtIns(4,5)P2 in the cell membrane is regulated
in a complex manner by a network of PI-kinases and PI-
phosphatases and PLC [9^11]. In the classic pathway phos-
phatidylinositol is phosphorylated to PtIns(4,5)P2 by two suc-
cessive reactions catalyzed by PI4-kinases and phosphatidyl-4-
phosphate 5-kinases (PI(4)P5-K). Manipulation of PI-kinase
activity by overexpression of a PI(4)P5-K in a heterologous
expression system has been demonstrated to a¡ect sensitivity
of co-expressed KATP channels to ATP, demonstrating the
role of this phospholipid for physiological activity of this
channel, whose pore-forming subunit (Kir6.x) represents an-
other member of the Kir family [12].
In the present study the K-isoform of a PI(4)P5-K originally
cloned from the MIN6 murine pancreatic cell line [13] was
expressed in adult rat atrial myocytes. These cells endoge-
nously express functional GIRK1/GIRK4 channels, K1a ad-
renergic receptors and ETA receptors, both coupling to
Gq=11, resulting in activation of PLC. This approach was
used to study, (i) if the endogenous (basal) level of
PtIns(4,5)P2 in the membrane is limiting activation of
GIRK channels by M2 receptors, and (ii) if increasing
PtIns(4,5)P2 synthesis a¡ects inhibition of GIRK current via
PLC-coupled receptors.
It was found that transfection with the PI(4)P5-K-encoding
vector did not a¡ect density of ACh-induced GIRK current or
its activation rate respectively. Acute desensitization of whole
cell current, which represents a fast and reversible decay of
0014-5793 / 02 / $22.00 D 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 3 4 2 6 - 9
*Corresponding author. Fax: (49)-234-3214449.
E-mail address: lutz.pott@ruhr-uni-bochum.de (L. Pott).
Abbreviations: GIRK, G protein-activated inward-rectifying Kþ
channel; ET, endothelin; PtIns(4,5)P2, phosphatidylinositol 4,5-bis-
phosphate; PI(4)P5-K, phosphatidyl-4-phosphate 5-kinase; PLC,
phospholipase C
FEBS 26607 27-9-02
FEBS 26607FEBS Letters 529 (2002) 356^360
IKðAChÞ observed upon rapid exposure of a cell to a high con-
centration of ACh or other activating agonists and most likely
re£ects a property of the channel complex [14] was not af-
fected either. Inhibition of guanosine triphosphate (GTP)-Q-S
stimulated GIRK current, following activation of the PLC-
coupled signalling pathway by exposure to ET-1 or the K-ad-
renergic agonist phenylephrine respectively, was completely
abolished in transfected myocytes. These results support the
notion that in atrial myocytes and presumably in other sys-
tems, GIRK channels can be regulated by PLC-coupled re-
ceptors via depletion of PtIns(4,5)P2. This phospholipid there-
fore, in the system under study, ful¢lls the criteria of a second
messenger, apart from IP3 and DAG, of the receptor^Gq=11^
PLC pathway. Moreover, without stimulation of PLC-
coupled receptors, the endogenous level of PtIns(4,5)P2 does
not appear to be limiting normal function of GIRK channels
in their native environment.
2. Materials and methods
2.1. Isolation and culture of atrial myocytes
Experiments were performed with local ethics committee approval.
Wistar Kyoto rats of either sex (around 200 g) were anaesthetized by
i.v. injection of urethane (1 g/kg). The chest was opened and the heart
was removed and mounted on the cannula of a sterile Langendor¡
apparatus for coronary perfusion at constant £ow. The method of
enzymatic isolation of atrial myocytes and culture conditions have
been described in detail elsewhere (e.g. reference [15]). Myocytes
were used experimentally from day 0 until day 5 after isolation. No
e¡ects of time in culture were found as for the key experiments.
2.2. Solutions and chemicals
For whole cell measurements of atrial GIRK current an extracel-
lular solution of the following composition was used (mmol/l): NaCl
120; KCl 20; CaCl2 0.5; MgCl2 1.0; HEPES/NaOH 10.0, pH 7.4.
The solution for ¢lling the patch-clamp pipettes for whole cell mea-
surements of G protein-activated Kþ currents contained (mmol/l):
K-aspartate 110; KCl 20; NaCl 5.0, MgCl2 1.0; Na2ATP 2.0;
EGTA 2.0; GTP 0.01; HEPES/KOH 10.0, pH 7.4. Standard chem-
icals were from Merck (Darmstadt, Germany). EGTA, HEPES,
MgATP, GTP, GTP-Q-S ACh-chloride, ET-1, phenylephrine, and me-
thoxamine were from Sigma (Deisenhofen, Germany).
2.3. Current measurement
Membrane currents were measured using whole cell patch clamp.
Pipettes were fabricated from borosilicate glass and were ¢lled with
the solution listed above (DC resistance 4^6 M6). Currents were
measured by means of a patch-clamp ampli¢er (WPC-100, ESF, Go«t-
tingen, Germany). Signals were analogue ¢ltered (corner frequency of
1^3 kHz), digitally sampled at 5 kHz and stored on a computer,
equipped with a hardware/software package (ISO2 by MFK, Frank-
furt/Main, Germany) for voltage control and data acquisition. Experi-
ments were performed at ambient temperature (22^24‡C). If not oth-
erwise stated, cells were voltage-clamped at 390 mV, i.e. negative to
EK, resulting in inward Kþ currents. Current^voltage relations were
determined by means of voltage ramps between 3120 mV and +60 mV
within 500 ms. Rapid superfusion of the cells for application and
withdrawal of agonist-containing solutions was performed by means
of a solenoid-operated £ow system that permitted switching between
up to six di¡erent solutions with a half time of exchange 9 100 ms.
2.4. Transfection of myocytes
The cDNA encoding for murine type I PI(4)P5-K K-isoform [16]
(kindly provided Dr. Y. Oka, Yamaguchi, Japan) was subcloned
into the pAdTrack-CMV vector using SalI and XbaI sites (pAd-
PI(4)P5-K). The pAdTrack-CMV vector was kindly provided by Dr.
B. Vogelstein (Howard Hughes Medical Institute, Baltimore, MD,
USA). This vector encodes for GFP as reporter for transfection-pos-
itive cells. Transfection was performed using Lipofectamine Plus re-
agent, according to the manufacturers instructions. Electrophysiolog-
ical recordings were made on days 3 and 4 after transfection.
Transfected cells (6 5%) were identi¢ed by epi£uorescence of GFP
(excitation wavelength 470 nm).
2.5. Statistics
Data are presented as meanSS.D. and were analyzed using Stu-
dent’s t-test for unpaired samples. A value of P6 0.05 was considered
to be signi¢cant.
3. Results
We ¢rst investigated if expression of PI(4)P5-K a¡ects basic
properties of GIRK current activated by stimulation of
Fig. 1. Transfection with PI(4)P5-K vector does not a¡ect ACh-activated current (20 Wmol/l). A: Representative sample recordings from a myo-
cyte transfected with the empty pAdTrack vector (left) and pAd-PI(4)P5-K (right). B: Summarized data on current densities. C: Summarized
data on acute desensitization; to qualitatively assess acute (channel) desensitization without contamination by receptor desensitization [38], ra-
tios of current at 10 s after starting superfusion with ACh-containing solution divided by peak inward current were determined. Di¡erences be-
tween controls and transfected cells were not signi¢cant. (n=8 for each group).
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M2AChR. Representative current recordings shown in Fig.
1A and summarized data on current densities (B), and acute
desensitization (C) reveal no di¡erences in these parameters
between control cells and myocytes transfected with the empty
pAdTrack-CMV vector. Corresponding results were obtained,
when the Gi=o-coupled pathway was stimulated by adenosine
via A1 receptors (not shown). This is in line with a previous
study demonstrating that inclusion of PtIns(4,5)P2 in the pi-
pette ¢lling solution does not a¡ect these properties of GIRK
current in atrial myocytes [7] and lends supports to the notion
that the endogenous level of PIP2 is not a limiting factor for
normal (basal) function of atrial GIRK channels and their
activation by Gi=o-coupled receptors.
Exposure of atrial myocytes to ET1, in line with previous
studies [7,17,18] results in slow activation of GIRK current,
most likely re£ecting some promiscuous coupling of the ETA
receptor to Gi=o and inhibition of the current activated by
ACh via stimulation of M2AChR as illustrated in Fig. 2.
The superposition of activation and inhibition shows a large
variability between individual cells. Moreover upon activation
of IKðAChÞ by ET-1 some heterologous desensitization of the
response to ACh occurs [7] that cannot be distinguished from
a genuine inhibition. Comparable e¡ects, i.e. variable degrees
of activation and inhibition were found when K1 receptors
were stimulated by phenylephrine or methoxamine respec-
tively (not shown, see reference [7]).
We therefore used an experimental protocol that allows
studying the inhibitory component without contamination
by activation or acute desensitization. For this purpose
GTP-Q-S (500 Wmol/l) was routinely included in the pipette
¢lling solution. After a period of V2 min following rupture
of the membrane, one or a series of exposures to ACh resulted
in irreversible activation of IKðAChÞ, which apart from a slow
‘rundown’ in the order of 20% within V5 min, remained
fairly stable. Upon exposure of a GTP-Q-S-loaded myocyte
to Phe (100 Wmol/l) under this condition, the current decayed
with a half time in the order of magnitude of 1 min, in line
with our previous study. Fig. 3A,B shows representative
traces demonstrating the e¡ect of Phe on GTP-Q-S-activated
GIRK current in a control myocyte (transfected with the
empty vector) and a pAd-PI(4)P5-K transfected cell. The in-
hibition caused by K1 receptor stimulation on average
amounted to about 70% in myocytes transfected with the
empty vector or non-tranfected cells respectively. The inhibi-
tion was signi¢cantly reduced to 20%, i.e. to the baseline run-
down level in the group of transfection-positive myocytes
(Fig. 3B). Comparable results were obtained, when ET1
(10 nM/l) was used as PLC-activating agonist (Fig. 3C,D).
The summarized data in Fig. 4 reveal that GIRK current in-
hibition caused by activation of ETA-R or K1a-R respectively
was reduced to baseline in cells overexpressing the kinase.
Fig. 2. Simultaneous activation and inhibition of GIRK current by
ET-1. ACh (20 Wmol/l) and ET-1 (10 nmol/l) were applied as indi-
cated by the horizontal bars. The arrowhead indicates a gap in the
recording of 40 s.
Fig. 3. Sample recordings demonstrating e¡ects of ET-1 (A,B) and phenylephrine (C,D) on GTP-Q-S activated GIRK current. In this series of
experiments GTP-Q-S was included in the pipette ¢lling solution (500 Wmol/l). Cells were repetitively challenged by ACh (20 Wmol/l) until a sta-
ble level of current activation was reached. ACh and ET-1 or Phe were applied as indicated by the horizontal bars.
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These data clearly demonstrate that increasing an enzyme
activity, which contributes to the synthesis of PtIns(4,5)P2
counteracts the inhibition of an ion channel whose depen-
dence on PtIns(4,5)P2 has been demonstrated previously.
4. Discussion
GIRK channels are activated by direct interaction with LQ
subunits released from heterotrimeric G proteins preferentially
but not exclusively of the pertussis toxin-sensitive class (Gi=o)
upon agonist stimulation of appropriate receptor species
[19,20]. Apart from this canonical activating pathway other
regulatory factors have been identi¢ed, such as intracellular
Naþ, which appears to be closely linked to regulation by
PtIns(4,5)P2 [21]. Phosphorylation by PKA has been sug-
gested to exert a facilitatory e¡ect GIRK currents in atrial
cells [22], which is, however contradictory to studies from
other laboratories [23^26]. A complex regulatory pathway
modulating voltage-dependent relaxation of GIRK current
has been delineated recently [27,28]. According to these stud-
ies, there is a tonic inhibition of GLQ -induced channel activity
by RGS4 that is reduced by phosphatidylinositol-3,4,5,-tris-
phosphate (PIP3). This regulation becomes voltage dependent,
since Ca2þ entry, via formation of Ca2þ/calmodulin, reverses
the action of PIP3.
Phosphoinositide metabolism plays an essential role in nu-
merous cellular processes, and controlled synthesis and enzy-
matic breakdown of phosphoinosites are fundamental signal-
ling events. Sensitivity to PtIns(4,5)P2 is a property that is
shared with other members of the family of inwardly rectify-
ing Kþ (Kir.x) channels, such as ATP-sensitive Kþ channels
composed of Kir6.x pore-forming K-subunits and SUR L-sub-
units [29^32] or the renal ROMK1 channel [33]. However,
also channels belonging to other families have been shown
to be sensitive to PtIns(4,5)P2 (e.g. [34,35]). The mechanism(s)
of how PtIns(4,5)P2 a¡ects channel gating are not identical in
di¡erent channels or other membrane proteins. In KðATPÞ
channels increasing PtIns(4,5)P2 results in a decreased appar-
ent a⁄nity for ATP, the physiological inhibitor of channel
gating [12]. Evidence has been provided that this re£ects a
competition between ATP and PtIns(4,5)P2 for a C-terminal
binding site on the Kir6.x subunit [36]. For the GIRK chan-
nels it is assumed that binding of PtIns(4,5)P2 to its subunits
is conditional for gating, and that GLQ stabilizes the interac-
tions between the channel subunit and the phosphoinositide.
Although GIRK channel gating strongly depends on the pres-
ence of PtIns(4,5)P2 [21,37] suggesting a regulatory role, it is
not clear if basal function of this channel in its native environ-
ment is limited by the concentration of this phosphoinositide.
The lack of an e¡ect of overexpressing PI(4)P5-K on ACh-
induced current under basal conditions clearly suggests that
PtIns(4,5)P2 is not a limiting component for basal function.
However, stimulation of endogenous receptors that result in
breakdown of PtIns(4,5)P2 results in inhibition of GIRK
channel activity, providing a crosstalk between Gi=o- and
Gq=11-coupled pathways. At present little is known about reg-
ulation of PI(4)P5-K activities by receptor-mediated signals.
Such a regulation might provide an additional modulatory
input to this system.
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